{"id":"W2040176056","doi":"10.1007/s00280-009-1041-6","title":"A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation","year":2009,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital Notre-Dame; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Lapatinib; Pharmacokinetics; Medicine; Toxicity; Pharmacology; Gastroenterology; Phases of clinical research; Internal medicine; Oral administration; Cancer; Breast cancer; Trastuzumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001862588,0.0001768933,0.0005125653,0.0001142076,0.00003393174,0.000003850789,0.00003831388,0.0001254263,0.0002136979],"category_scores_gemma":[0.00001732092,0.0001292293,0.00009185547,0.0001293441,0.0001046956,0.00003690671,0.00001426326,0.0001852549,7.153284e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004260766,"about_ca_system_score_gemma":0.00006108458,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001367149,"about_ca_topic_score_gemma":0.000006176808,"domain_scores_codex":[0.9988465,0.00007446583,0.000497415,0.000278652,0.000108975,0.0001940128],"domain_scores_gemma":[0.9994196,0.0001204069,0.0001764993,0.00008892584,0.00005313604,0.0001414009],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.09824826,0.01230354,0.03700138,0.00006279305,0.0003795817,0.00008231888,0.0005149629,0.00001180842,0.0769966,0.00004043502,0.001871793,0.7724865],"study_design_scores_gemma":[0.7706048,0.03628714,0.03310954,0.0001294571,0.000646791,0.0000258967,0.00002143986,0.00471476,0.1385519,0.0001379237,0.0154664,0.0003039014],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914737,0.002280501,0.00002328944,0.004603941,0.0005347071,0.0009912007,0.00002083432,0.00001543175,0.00005643858],"genre_scores_gemma":[0.9876,0.008831218,0.0001545873,0.003138896,0.0001442026,0.00008571372,0.000009664936,0.00001228535,0.00002339608],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7721826,"threshold_uncertainty_score":0.5269818,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02916190242965619,"score_gpt":0.4183574430505823,"score_spread":0.389195540620926,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}